Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Switzerland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20101
20111
20134
20182
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
ECRI bv2
Novartis Pharmaceuticals2
Abbott Medical Devices1
AstraZeneca1
CSL Behring1
Cardiocentro Ticino1
Centre Hospitalier Universitaire Vaudois1
Cordis US Corp.1
Deutsches Herzzentrum Muenchen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease15
Acute Coronary Syndrome4
Myocardial Infarction3
Stroke3
Atherosclerosis2
Cardiovascular Diseases2
Coronary Stenosis2
Heart Diseases2
Peripheral Arterial Disease2
Angina Pectoris1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.